These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3471528)
21. Aclacinomycin A and behenoyl arabinofuranosylcytosine combination chemotherapy for previously untreated acute leukemia. Sampi K; Sakurai M; Kaneko Y; Hattori M Oncology; 1986; 43(1):18-22. PubMed ID: 3455751 [TBL] [Abstract][Full Text] [Related]
22. [Aclacinomycin A and behenoyl ara-C combination chemotherapy for untreated acute non-lymphocytic leukemia]. Sampi K; Honda T; Hayashi Y; Hattori M Gan To Kagaku Ryoho; 1983 Oct; 10(10):2211-6. PubMed ID: 6578705 [TBL] [Abstract][Full Text] [Related]
23. [Gastrointestinal symptoms of aclacinomycin A in patients with adult acute nonlymphocytic leukemia--comparison of BH-AC-DMP therapy and BH-AC-AMP therapy]. Kawano F; Tajima H; Matsuoka Y; Asou N; Takatsuki K Rinsho Ketsueki; 1985 Apr; 26(4):494-8. PubMed ID: 3862889 [No Abstract] [Full Text] [Related]
24. [Use of arterial infusion of neocarzinostatin with or without combination chemotherapy as a treatment of carcinoma of the prostate]. Yuasa M; Numata A; Tanaka T; Kawanishi Y; Yamamoto A; Imagawa A Gan To Kagaku Ryoho; 1986 Jul; 13(7):2325-30. PubMed ID: 2425748 [TBL] [Abstract][Full Text] [Related]
25. Phase I and pharmacokinetic study of high volume intraperitoneal aclacinomycin-A (Aclarubicin). Kerr IG; Archer S; DeAngelis C; Farrell S; Hanna S; McKee J Invest New Drugs; 1987; 5(2):171-6. PubMed ID: 3477533 [TBL] [Abstract][Full Text] [Related]
26. Combination therapy with aclacinomycin in acute leukemia. Krc I; Myslivecek M; Mlcochová E Acta Univ Palacki Olomuc Fac Med; 1986; 113():141-7. PubMed ID: 2941978 [No Abstract] [Full Text] [Related]
27. [Studies on hematological diseases in elderly patients. Part 4: Chemotherapeutic effect of aclarubicin (ACR) on acute nonlymphocytic leukemia in the aged]. Yorimitsu S; Takahashi I; Lai M; Ohmoto E; Aoyama S; Inagaki T; Ueda I; Nishimura M; Nakada H; Nonaka K Nihon Ronen Igakkai Zasshi; 1986 May; 23(3):302-8. PubMed ID: 3463814 [No Abstract] [Full Text] [Related]
28. Systemic therapy of metastatic breast cancer. Rose C Acta Oncol; 1990; 29(3):361-5. PubMed ID: 2363947 [TBL] [Abstract][Full Text] [Related]
29. [Polychemotherapy versus monotherapy in metastatic breast carcinoma]. Tanner J; Dunst J Strahlenther Onkol; 1999 Sep; 175(9):471. PubMed ID: 10518983 [No Abstract] [Full Text] [Related]
30. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia]. Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050 [TBL] [Abstract][Full Text] [Related]
31. Phase I-II trial of aclacinomycin A given in a four-consecutive-day schedule to patients with solid tumours. A South-East European Oncology Group (SEEOG) Study. Kerpel-Fronius S; Gyergyay F; Hindy I; Decker A; Sawinsky I; Fäller K; Mechl Z; Nekulova M; Kolaric K; Tomek R Oncology; 1987; 44(3):159-63. PubMed ID: 3474571 [TBL] [Abstract][Full Text] [Related]
32. Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer. Nabholtz JM; Smylie M; Mackey JR; Noel D; Paterson AH; al-Tweigeri T; Au D; Sansregret E; Delorme F; Riva A Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):37-41. PubMed ID: 9364541 [TBL] [Abstract][Full Text] [Related]
33. [Aclarubicin-related pancreatitis in a child with AML]. Adachi S; Akiyama Y; Takimoto T; Tanizawa A; Kiriyama Y; Kubota Y; Mikawa H Rinsho Ketsueki; 1988 Mar; 29(3):385-8. PubMed ID: 3165144 [No Abstract] [Full Text] [Related]
34. Selective drug delivery to peri-tumoral region and regional lymphatics by local injection of aclarubicin adsorbed on activated carbon particles in patients with breast cancer--a pilot study. Hagiwara A; Takahashi T; Sawai K; Sakakura C; Shirasu M; Ohgaki M; Imanishi T; Yamasaki J; Takemoto Y; Kageyama N Anticancer Drugs; 1997 Aug; 8(7):666-70. PubMed ID: 9311442 [TBL] [Abstract][Full Text] [Related]
36. Preliminary results of an induction combination regimen including fractionated anthracycline. Krieger O; Bernhart M; Fiedler E; Kasparu H; Weber E; Lutz D Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():66. PubMed ID: 2627610 [No Abstract] [Full Text] [Related]
37. Phase II study of vinorelbine and ifosfamide in anthracycline resistant metastatic breast cancer. Pronzato P; Queirolo P; Landucci M; Vaira F; Vigani A; Gipponi M; Cafiero F Breast Cancer Res Treat; 1997 Jan; 42(2):183-6. PubMed ID: 9138607 [TBL] [Abstract][Full Text] [Related]
38. Review of docetaxel/doxorubicin combination in metastatic breast cancer. Diéras V Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):31-3. PubMed ID: 9364539 [TBL] [Abstract][Full Text] [Related]